Academic Clinical Trials Program
Leukemia & Lymphoma Society
UM Funding ID
FD03320
Sponsor
Leukemia & Lymphoma Society
Program
Category
International
Description
The LLS ACT initiative is a clinical trial award program designed to develop cutting edge treatments that will have meaningful impact for blood cancer patients. LLS Research portal.
Funding available up to $1 million USD for up to three years.
Results Announced: May 2024
VPRI Contact
James De Castro
Contracts CoordinatorJames [dot] .DeCastro [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 25-Oct-2023 3:00 pm EST |
Application (Upon Invitation Only) | 12-Jan-2024 4:30 pm CST | 23-Sep-2024 3:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.